Solenic Medical’s alternating magnetic field technology was successfully used for orthopedics following the FDA’s compassionate use authorization, according to an Oct. 21 news release.
The noninvasive technology, designed to treat orthopedic implant infections, was used as an adjunct to surgery for a patient with a serious medical condition involving a prosthetic joint infection. There haven’t been any device-related adverse events reported.
FDA compassionate authorization allows patients with a serious or immediately life-threatening condition to access a device. Solenic’s technology is an investigational device.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.